Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: A retrospective chart review

Neonatology

Volumn 99, Issue 1, 2010, Pages 32-37

  Nakwan, Narongsak ^a   Nakwan, Narongwit ^a   Wannaro, Jeerawan ^a  

^a Hat Yai Hospital   (Thailand)

Author keywords

Beraprost sodium; Newborn infant; Persistent pulmonary hypertension of the newborn

Indexed keywords

ADRENALIN; ALKALI; BERAPROST; DOPAMINE; INOTROPIC AGENT; OXYGEN;

ARTICLE; BIRTH WEIGHT; CARDIOPULMONARY ARREST; CARDIOPULMONARY HEMODYNAMICS; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DEVELOPMENTAL DISORDER; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HEART RATE; HIGH FREQUENCY VENTILATION; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; INFANT; MALE; MEDICAL RECORD REVIEW; NEWBORN; OXYGEN CONSUMPTION; OXYGENATION; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

BLOOD PRESSURE; EPOPROSTENOL; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; INFANT, NEWBORN; MALE; PERSISTENT FETAL CIRCULATION SYNDROME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77953943786     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000298137     Document Type: Article

References (24)

1. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, et al: Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105:14-20.
2. Finer NN, Barrington KI: Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006;4: CD000399.
3. Sadiq HF, Mantych G, Benawra RS, Devaskar UP, Hocker JR: Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial. J Perinatol 2003;23:98-103.
4. Travadi JN, Patole SK: Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 2003;36:529-535.
5. Bassler D, Choong K, McNamara P, Kirpalani H: Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006;89:1-5.
6. Ehlen M, Wiebe B: Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young 2003;13:361-363.
7. Okano Y, Yoshioka T, Shimouchi A, Satoh T, Kunieda T, et al: Orally active prostacyclin analogue in primary pulmonary hypertension. Lancet 1997;349:1365.
8. Ikeda D, Tsujino I, Sakaue S, Ohira H, Itoh N, Kamigaki M, et al: Pilot study of shortterm effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension. Circ J 2007;71:1829-1831.
9. Suzuki H, Sato S, Tanabe S, Hayasaka K: Beraprost sodium for pulmonary hypertension with congenital heart disease. Pediatr Int 2002;44:528-529.
10. Limsuwan A, Pienvichit P, Khowsathit P: Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease. Pediatr Cardiol 2005;26:787-791.
11. Badesh DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, et al: Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:56S-61S.
12. Greenough A, Khetriwal B: Pulmonary hypertension in the newborn. Paediatr Respir Rev 2005;6:111-116.
13. Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, et al: Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 2004;102:139-153.
14. Yuki H, Sato S, Arisaka Y, Kato S, Tomoike H: Orally administered beraprost sodium inhibits pulmonary hypertension induced by monocrotaline in rats. Tohoku J Exp Med 1994;173:371-375.
15. Nishio S, Matsuura H, Kanai N, Fukatsu Y, Hirano T, Nishikawa N, et al: The in and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species. Jpn J Pharmacol 1988;47:1-10.
16. Ichida F, Uese K, Hashimoto I, Hamamichi Y, Tsubata S, Fukahara K, et al: Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children. J Cardiol 1997;29:217-224.
17. Ichida F, Uses K, Tsubata S, Hamamichi Y, Fukahara K, Murakami A, et al: Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension. Am J Cardiol 1997;80:662-664.
18. Saji T, Ozawa Y, Ishikita T, Matsuura H, Matsuo N: Short-term hemodynamic effect of a new oral PGI 2 analogue, beraprost, in primary and secondary pulmonary hypertension. Am J Cardiol 1996;78:244-247.
19. Akita T, Miyazaki M, Toda N: Vasodilator actions of TRK-100, a new prostaglandin T 2 analogue. Br J Pharmacol 1986;89:703-711.
20. Galiè N, Humbert M, Vachiéry JC, Vizza CD, Kneussl M, Manes A, et al: Beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002;39:1496-1502.
21. Baquero H, Soliz A, Neira F, Venegas ME, Sola A: Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006;117:1077-1083.
22. Simiyu DE, Okello C, Nyakundi EG, Tawakal AH: Sildenafil in management of persistent pulmonary hypertension of the newborn: report of two cases. East Afr Med J 2006;83:337-340.
23. Vargas-Origel A, Gómez-Rodríguez G, Aldana-Valenzuela C, Vela-Huerta MM, Alarcón-Santos SB, Amador-Licona N: The use of sildenafil in persistent pulmonary hypertension of the newborn. Am J Perinatol 2010;27:225-230.
24. Juliana AE, Abbad F: Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 2005;164:626-629.